Engineering B cells with mRNA

Methods in Molecular Biology

Volumn 969, Issue , 2013, Pages 101-110

  Lee, Jaewoo ^a   Boczkowski, David ^a   Nair, Smita ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B cells; Electroporation; Multiple mRNA co transfection

Indexed keywords

B7 ANTIGEN; CD137 LIGAND; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 12P70; MESSENGER RNA; OVALBUMIN; OX40 LIGAND; ANTIGEN; IL12A PROTEIN, HUMAN; IL12B PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD8+ T LYMPHOCYTE; CELL ENGINEERING; CHICKEN; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO STUDY; GENETIC TRANSFECTION; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; REVIEW;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, CD; B-LYMPHOCYTES; CELL ENGINEERING; HUMANS; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; LYMPHOCYTE ACTIVATION; RNA, MESSENGER; TRANSFECTION;

MLCS; MLOWN;

EID: 84878653513     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-260-5_7     Document Type: Article

References (21)

1. Bringmann A, Held SA, Heine A, Brossart P (2010) RNA vaccines in cancer treatment. J Biomed Biotechnol 2010:623687
2. Kyte JA, Gaudernack G (2006) Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells. Cancer Immunol Immunother 55:1432-1442
3. Boczkowski D, Nair S (2010) RNA as performance-enhancers for dendritic cells. Expert Opin Biol Ther 10:563-574
4. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN (2001) Highly ef ficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98:49-56
5. Schultze JL, Grabbe S, von Bergwelt-Baildon MS (2004) DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. Trends Immunol 25:659-664
6. Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler LM (1997) CD40-activated human B cells: an alternative source of highly ef ficient antigen presenting cells to generate autologous antigen-speci fic T cells for adoptive immunotherapy. J Clin Invest 100:2757-2765
7. Shirota H, Sano K, Hirasawa N, Terui T, Ohuchi K, Hattori T, Tamura G (2002) B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. J Immunol 169:787-794
8. Kondo E, Topp MS, Kiem HP, Obata Y, Morishima Y, Kuzushima K, Tanimoto M, Harada M, Takahashi T, Akatsuka Y (2002) Ef ficient generation of antigen-speci fic cytotoxic T cells using retrovirally transduced CD40-activated B cells. J Immunol 169:2164-2171
9. Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P (2003) CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate speci fic T cells. Cancer Res 63:2836-2843 [see comment]
10. Kondo E, Akatsuka Y, Kuzushima K, Tsujimura K, Asakura S, Tajima K, Kagami Y, Kodera Y, Tanimoto M, Morishima Y, Takahashi T (2004) Identi fication of novel CTL epitopes of CMV-pp 65 presented by a variety of HLA alleles. Blood 103:630-638
11. Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, Tuma E, Giese T, Ellwart JW, Endres S, Hartmann G (2004) IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol 172:954-963
12. Heit A, Huster KM, Schmitz F, Schiemann M, Busch DH, Wagner H (2004) CpG-DNA aided cross-priming by cross-presenting B cells. J Immunol 172:1501-1507
13. von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, Debey S, Draube A, Maecker B, Menezes I, Nadler LM, Schultze JL (2006) CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. Blood 107:2786-2789
14. Croft M, Duncan DD, Swain SL (1992) Response of naive antigen-speci fic CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements. J Exp Med 176:1431-1437
15. Cassell DJ, Schwartz RH (1994) A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J Exp Med 180:1829-1840
16. Subklewe M, Sebelin K, Block A, Meier A, Roukens A, Paludan C, Fonteneau JF, Steinman RM, Munz C (2005) Dendritic cells expand Epstein Barr virus speci fic CD8+ T cell responses more ef ficiently than EBV transformed B cells. Hum Immunol 66:938-949
17. Oizumi S, Deyev V, Yamazaki K, Schreiber T, Strbo N, Rosenblatt J, Podack ER (2008) Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells. J Immunother 31:394-401
18. Lee J, Dollins CM, Boczkowski D, Sullenger BA, Nair S (2008) Activated B cells modi fied by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-speci fic T-cell responses. Immunology 125:229-240
19. Dannull J, Nair S, Su Z, Boczkowski D, DeBeck C, Yang B, Gilboa E, Vieweg J (2005) Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand. Blood 105:3206-3213
20. Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E (2000) Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA ampli fied from tumor cells. Cancer Res 60:1028-1034
21. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, vol 1-3, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 7.43-7.45